Home

Headlines Weather Search

News

Sports

Business

World

Radio

Radio Fiji One Mirchi FM Gold FM Bula FM 2Day FM Radio Fiji Two

TV

FBC TV FBC Sports FBC 2
2019 Flying Fijians RWC Squad
1
Campese Ma'afu
LH Prop
2
Eroni Mawi
LH Prop
3
Peni Ravai
LH Prop
4
Mesulame Dolokoto
Hooker
5
Samuel Matavesi
Hooker
6
Ratu Vere Vugakoto
Hooker
7
Leeroy Atalifo
TH Prop
8
Manasa Saulo
TH Prop
9
Kalivati Tawake
TH Prop
10
Tevita Cavubati
Lock
11
Leone Nakarawa
Lock
12
Api Ratuniyarawa
Lock
13
Tevita Ratuva
Backrow
14
Semi Kunatani
Backrow
15
Viliame Mata
Backrow
16
Mosese Voka
Backrow
17
Dominiko Waqaniburotu
Backrow
18
Peceli Yato
Backrow
19
Frank Lomani
Halfback
20
Nikola Matawalu
Halfback
21
Henry Seniloli
Halfback
22
Levani Botia
Inside Back
23
Jale Vatubua
Inside Back
24
Ben Volavola
Inside Back
25
Vereniki Goneva
Outside Back
26
Filipo Nakosi
Outside Back
27
Waisea Nayacalevu
Outside Back
28
Semi Radradra
Outside Back
29
Josua Tuisova
Outside Back
30
Joshua Matavesi
Utility Back
31
Alivereti Veitokani
Utility Back
32
Kini Murimurivalu
Fullback

World

'Female Viagra' gets US approval

August 19, 2015 6:14 pm

Flibanserin, a drug produced by Sprout Pharmaceuticals, recently passed an FDA advisory committee meeting.

The pill is designed to assist premenopausal women regain their sex drive by boosting levels of certain brain chemicals.

The drug has been criticised as having marginal effects.

Article continues after advertisement

Versions of the pill, which will be marketed as “Addyi”, have been submitted for approval in the past but never passed.

It was rejected by the FDA twice for lack of effectiveness and side effects like nausea, dizziness and fainting.

Women taking the drug reported between half and one more sexually satisfying event per month – results experts admitted were “modest”.

Originally the drug was produced by German company Boehringer Ingelheim.

Sprout bought the drug from that company after it was turned down by the FDA.

Documents from the 4 June FDA advisory meeting describe the drug’s purpose as “treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women”.

Women would take it each night.

A doctor would have to determine whether a woman seeking the pill was suffering from a disorder characterised by a lack of sexual fantasies and desire, causing the woman distress.

Currently, there is nothing on the US market approved for treatment of HSDD or another condition, female sexual interest/arousal disorder (FSIAD).

“This condition is clearly an area of unmet medical need,” the FDA documents said.
Sprout only has 25 employees. Large pharmaceutical companies like Pfizer, Bayer and Proctor & Gamble have all studied female sexual desire disorder treatment but abandoned plans to pursue it.

Sprout CEO Cindy Whitehead told AP they would promote Addyi carefully.
“We would never want a patient who’s not going to see a benefit to take it and tell everyone it doesn’t work,” she said.

Lobbying by Sprout Pharmaceuticals was backed by the women’s rights group Even the Score, which has accused the FDA of gender bias by approving a number of drugs treating erectile dysfunction in men without passing an equivalent for women.

Keep Connected With The Latest News, Weather, And Sports on Fiji's Best Radio stations.

Live Tune In
  • 95.4 FM
  • Suva, Nadi, Lautoka, Labasa
  • 95.2 FM
  • Sigatoka, Ba
  • 95.6 FM
  • Tavua
  • 95.8 FM
  • Rakiraki
Live Tune In
  • 102.6 FM
  • Suva, Nadi, Lautoka, Labasa
  • 102.4 FM
  • Sigatoka, Ba
  • 102.8 FM
  • Tavua
  • 103.0 FM
  • Rakiraki
Live Tune In
  • 97.8 FM
  • Suva, Nadi, Lautoka, Labasa
  • 97.6 FM
  • Sigatoka, Ba
  • 98.0 FM
  • Tavua
  • 98.2 FM
  • Rakiraki
Live Tune In
  • 93.0 FM
  • Suva, Nadi, Lautoka, Labasa
  • 92.8 FM
  • Sigatoka, Ba
  • 93.2 FM
  • Tavua
  • 93.4 FM
  • Rakiraki
Live Tune In
  • 100.2 FM
  • Suva, Nadi, Lautoka, Labasa
  • 100.0 FM
  • Sigatoka, Ba
  • 100.4 FM
  • Tavua
  • 100.6 FM
  • Rakiraki
Live Tune In
  • 105.0 FM
  • Suva, Nadi, Lautoka, Labasa
  • 104.8 FM
  • Sigatoka, Ba
  • 105.2 FM
  • Tavua
  • 105.4 FM
  • Rakiraki